Chugai pins diagnostics sales rise on success of DNA probes
This article was originally published in Clinica
Executive Summary
Diagnostics sales at Chugai were up 17% to ¥1.3 billion ($133 million) in the year ended March 1997. The Japanese pharmaceutical company attributes the rise to strong sales of DNA probes by Gen-Probe, its wholly-owned US subsidiary.